Clarient: NeoGenomics acquires Clarient and subsidiary for $275m
Cancer-focused genetic testing services provider NeoGenomics has agreed to acquire Clarient, the life sciences business unit of GE Healthcare, for approximately $275m.
Read full article »
Clarient develops an interface that enables businesses to upload, maintain and share legal entity data and hierarchy information with counterparties.
Read more